| 000 | 01849 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514064832.0 | ||
| 264 | 0 | _c20030701 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 024 | 7 |
_a10.4088/jcp.v64n0410 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzegedi, Armin | |
| 245 | 0 | 0 |
_aEarly improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cApr 2003 |
||
| 300 |
_a413-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAmbulatory Care |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xtherapeutic use |
| 650 | 0 | 4 |
_aDepressive Disorder _xdiagnosis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMianserin _xanalogs & derivatives |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMirtazapine |
| 650 | 0 | 4 |
_aParoxetine _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMüller, Matthias J | |
| 700 | 1 | _aAnghelescu, Ion | |
| 700 | 1 | _aKlawe, Christoph | |
| 700 | 1 | _aKohnen, Ralf | |
| 700 | 1 | _aBenkert, Otto | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 64 _gno. 4 _gp. 413-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/jcp.v64n0410 _zAvailable from publisher's website |
| 999 |
_c12507162 _d12507162 |
||